APOL1 OLIGOMERIZATION AS THE KEY MEDIATOR OF KIDNEY DISEASE IN AFRICAN AMERICANS

$662,398FY2014Department of the ArmyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators